Nine different KRAS mutations affecting codons 12 and 13 of exon 2 have been identified in NSCLC, as has been widely reported [http://cancer.sanger.ac.uk/cosmic (accessed on 20 January 2025)]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.